India’s largest Pro AV conference returns to the Jio World Convention Centre, Mumbai, 16–18 September 2026 — 80 speakers across 50-plus sessions and ten tracks, opening with Larsen & Toubro Group CIO Gopi Thangavel, with new on-site AVIXA CTS^® certification. Free to attend.

MUMBAI, India, Aug. 27, 2026 /PRNewswire/ — The InfoComm India 2026 Summit, the education programme at India’s largest Professional Audiovisual (Pro AV) and integrated experience technology trade show, will convene 80 speakers across more than 50 sessions when InfoComm India 2026 takes place at the Jio World Convention Centre (JWCC) in Mumbai from 16–18 September 2026. Free to attend and spanning ten specialised tracks across three stages, the conference brings India’s Pro AV, IT and end-user communities together to learn from the practitioners, decision-makers and institutions shaping the industry.

Part of India’s largest Pro AV showcase

The Summit anchors what is on track to be the largest InfoComm India to date. The 2026 edition spans five halls across two levels of JWCC — Pavilion Halls 1 to 3 and Jasmine Halls 1 to 2 — with the show floor now exceeding 10,600 net square metres, up more than 17% on 2025. More than 300 global brands will exhibit, led by Platinum Partners BenQ, Crestron, Epson, Harman, Shure and Vega. India’s momentum underpins the programme: according to AVIXA’s 2025 Industry Outlook and Trends Analysis (IOTA), the country is Asia Pacific’s fastest-growing Pro AV market, having overtaken China, within a global Pro AV market projected to grow from US$332 billion in 2025 to US$402 billion by 2030.

Headlining the programme: India’s next digital leap

The conference opens on Wednesday 16 September with the flagship Opening Session, “Leading India’s Next Digital Leap: Technology, Infrastructure and the Intelligent Enterprise,” headlined by Gopi Thangavel, Group CIO of Larsen & Toubro (L&T) — one of India’s largest engineering and infrastructure groups. Drawing on L&T’s work across infrastructure, manufacturing and smart built environments, the session examines how artificial intelligence, automation and intelligent infrastructure are reshaping both industry and public services — and the leadership and investment required to drive India’s next wave of digital growth. Sessions then run across ten tracks, from audio, digital signage and broadcast to unified communications, immersive technology, AI, enterprise IT and cybersecurity.

Featured sessions

• “Securing the Intelligent Workplace: Zero Trust for AV, IT & Collaboration” — Giri Kumar, India Head of IT/AV Engineering, Commonwealth Bank of Australia
• “The Most Expensive Room in the Building: Rethinking Collaboration in the AI Era” — Holger Reisinger, Senior Vice President, Video Business Unit, Jabra
• “The Pulse of Digital Signage: Global Trends, Managed Solutions & the Future of AI” — Florian Rotberg, Managing Director, invidis consulting
• “How 5G and IoT Are Transforming Connected AV Experiences” — edge computing and connected infrastructure, from smart workplaces to smart cities — N Ramesh, Deputy Director General (Technology), Department of Telecommunications, Government of India, and Sandeep Arora, VP Telecom Industry Platform, Capgemini
• “AI-Ready Workplaces: How AV, IT and Workplace Leaders Are Redefining Enterprise Collaboration” — Prashant Bishnoi, AI-Powered Workplace Partner Program Manager (Asia), Microsoft
• “The Future of Experience: Technology, Storytelling and Human Connection” — Stephen Thomas Cavit, President, Themed Entertainment Association (TEA) Asia Pacific Board
• “Smart Learning: AV Technology Transforming the Indian Classroom” — hybrid classrooms and smart campuses across higher education and K-12

Aligned with India’s national digital agenda

The 2026 programme leans into India’s national priorities. Sessions are co-organised with the Computer Society of India (Mumbai Chapter) on enterprise IT and cybersecurity; ICT Academy on skills and workforce readiness; invidis consulting on digital signage; and the Themed Entertainment Association (TEA) on immersive experience. Together with sessions on 5G, IoT and smart infrastructure, the programme speaks directly to the technology behind India’s Digital India — spanning the public sector, retail, healthcare and education. In all, it comprises 18 panel discussions and 22 expert presentations, plus the returning Smart Tech Stage.

Community and networking: Xchange LIVE

Beyond the sessions, the Summit hosts the AVIXA Xchange LIVE programme of community meet-ups — Newcomer, CTS and AV/IT gatherings, plus a Women’s Council meet-up — giving first-timers and seasoned professionals dedicated space to connect. It closes on Friday 18 September with a professional-development session, “InfoComm India AV Futures,” on where the industry goes next.

New for 2026: earn your CTS certification on-site

New this year, professionals can sit industry certification exams at the show for the first time. AVIXA will run on-site certification testing for the Certified Technology Specialist (CTS^®, CTS-D and CTS-I) and Audiovisual Network Professional (ANP^®) certifications, alongside prep courses for newcomers and experienced practitioners alike. The CTS credential is a globally recognised AV qualification held by more than 15,000 professionals worldwide and accredited to the ISO/IEC 17024 standard.

Exams run at JWCC on Wednesday 16 and Thursday 17 September (9:00 AM–12:00 PM and 2:00–5:00 PM IST) and Friday 18 September (9:00 AM–12:00 PM IST). Certified attendees can also earn Renewal Units (RUs) for the sessions they attend — on average five RUs per visit, making the show a fast route to maintaining certification.

The InfoComm India Summit has become the place where India’s AV and IT community comes to learn — and to lead. For 2026, it has paired the industry’s biggest conversations — AI, intelligent infrastructure and immersive experience — with the hands-on skills and certifications professionals need to act on them, so attendees can apply their learnings the very next day.

Registration

Visitor registration is free and open now. AV, IT and technology professionals can register to attend, and experience India’s vision for the future of Pro AV.

#InfoCommIndia2026  #TechMeetsTribe

About InfoComm India

Since its inception in 2013, InfoComm India has grown into the country’s leading platform connecting manufacturers, distributors, technology providers, system integrators, consultants, end users, enterprise buyers and government stakeholders across the Pro AV and integrated experience technology industry. It is one of three marquee events operated by InfoCommAsia Pte Ltd across the Asia Pacific region, alongside InfoComm China in Beijing and InfoComm Asia in Bangkok. Each show pairs a comprehensive exhibition with a Summit conference programme offering education on the latest industry trends and best practices.

About AVIXA

AVIXA^® (the Audiovisual and Integrated Experience Association) is the international trade association representing the professional audiovisual and integrated experience industry. Founded in 1939 and now home to more than 3,000 enterprise members representing over 20,000 AV professionals across more than 80 countries, AVIXA is the industry’s leading resource for standards, certification, training, market intelligence and thought leadership. InfoComm Asia serves as AVIXA’s flagship gathering for its communities across the region.

For more information, visit:

infocomm-asia.com | infocomm-china.com | infocomm-india.com 

HONG KONG, Aug. 27, 2026 /PRNewswire/ — As a premier global landmark in biotech, BIOHK2026 convenes international biotech hubs, cross-disciplinary industry forums, and high-impact networking events to accelerate cross-border partnerships in Hong Kong.

The official countdown is underway. With just two weeks until BIOHK2026 convenes at the Hong Kong Convention and Exhibition Centre (HKCEC) from September 9-12, 2026, BIOHK2026—organized by the Hong Kong Biotechnology Organization (HKBIO)—serves as a world-class international landmark event bridging biotech innovation, industrial capacity, venture capital, and regulatory bodies. Leveraging Hong Kong’s strategic position as Asia’s premier “Super-Connector” and biotech financing gateway, this 5th annual convention will welcome over 10,000 professional attendees, 400+ world-class speakers, and delegations spanning over 40 countries and regions.

To assist international delegates in maximizing their strategic footprint, HKBIO has published a comprehensive operational guide detailing the core pillars of this year’s convention.

1. Featured Exhibition Pavilions: Landmark Regional & International Innovation Clusters

Spanning expansive exhibition halls hosting nearly 200 global exhibitors, BIOHK2026 brings together prominent regional biotech hubs, state-backed industrial platforms.

Greater Bay Area & Mainland Innovation Hubs: Major regional delegations including Guangzhou and Shenzhen will showcase their dense biotech clusters, pioneering biotech enterprises, clinical trial capacity, and advanced biomanufacturing strength. A central spotlight will also be cast on the Hetao Shenzhen-Hong Kong Science and Technology Innovation Cooperation Zone, highlighting cross-border policy synergy, joint research initiatives, and frictionless data and sample flows between Hong Kong and Mainland China.

Leading Institutional & Corporate Delegations: Backed by Mainland China and connected to global markets, Hong Kong serves as an ideal pivot for biotech innovation. As a premier institutional partner, CITIC Group has joined hands with HKBIO for BIOHK2026. As a flagship implementation of CITIC’s strategy, this landmark partnership leverages abundant industrial resources, expert think tanks, and deep market entry experience to fully elevate the scale and international stature of the convention.

Nordic Future Health Pavilion: Co-organized by the Hong Kong Chamber of Commerce in Sweden (HKCCSE) and supported by the Consulate General of Sweden in Hong Kong and AstraZeneca Hong Kong, this dedicated pavilion brings around 10 leading Nordic life science enterprises and organizations directly to the main convention floor. Key participants will showcase breakthrough technologies spanning precision T-cell receptor-engineered T-cell therapies (Anocca), stromal cell therapies (NextCell Pharma), cancer immunotherapies and vaccines (ExpreS2ion Biotechnologies), digital health (Keeada Health, SoftMed), ophthalmology (Uveo), and biotech development (Veltio Pharma).

2. High-Impact Conference Program: 50+ Multi-Track Industry Forums

Across seven dynamic stages hosting over 400 world-class speakers, the four-day conference features high-level keynotes and more than 50 vertical forums bridging global biotech ecosystems:

Frontier Therapeutics & Advanced Sciences: Dedicated tracks covering AI-driven Drug Discovery & Healthcare, Cell and Gene Therapy (CGT) source innovation, Brain-Computer Interface (BCI), Synthetic Biology, Spatiotemporal Omics in infectious diseases, mRNA/Exosome therapies, Longevity & Anti-Aging science, and Modernization of Traditional Chinese Medicine (TCM) and other cutting-edge disciplines.

Global Regulatory, Clinical & Policy Frameworks: High-level keynotes and dedicated sessions exploring regulatory harmonization, highlighting the newly established Hong Kong Centre for Medical Products Regulation (CMPR), GBA Clinical Trial Collaboration via “One Institute, One Center”, and cross-border medical integration. Anchored by these initiatives, BIOHK2026 brings together top regional drug regulators—including representatives from Hong Kong, Singapore, Malaysia, Indonesia and Pakistan—to facilitate international collaboration and empower the global expansion of innovative therapeutics.

Global Cooperation Forum Series: Flagship international sessions exploring cross-border technology transfer, investment, and market access synergies across key global regions—including dedicated tracks for North America & Europe, Latin America, Southeast Asia/ASEAN, Belt and Road Economies, GBA, and specialized regional showcases like Hainan.

Biotech Investment & BD Summits: Capitalizing on Hong Kong’s position as the world’s second-largest biotech financing center—supported by HKEX Chapter 18A enabling non-revenue biotech listings and a robust capital ecosystem—forums will bring together corporate BD leads, investors, and dealmakers to analyze macro trends, primary vs. secondary market valuation, cross-border licensing, and value creation.

3. Concurrent Highlights: Strategic Matchmaking, Pitching & Executive Networking

Complementing the exhibition and conference tracks, BIOHK2026 features high-impact concurrent activities designed to convert participation into actionable dealmaking:

Integrated One2One Partnering Engine (Included with Delegate Pass): Every registered pass holder gains full access to the digital platform. Delegates can utilize multi-dimensional filters—categorizing counterparts by technology modalities, therapeutic focus, development stages, and specific collaboration goals—to pre-book 30-minute face-to-face sessions in dedicated private partnering suites at HKCEC.

BIOHK2026 Pitching Competition: Serving as a premier global launchpad for healthcare innovation, this competitive roadshow stage features high-potential biotech startups, university spin-offs, and early-stage innovators pitching platform technologies directly to rooms filled with global biotech investors, corporate BD leads, and industry mentors.

Regulatory Roundtables & Heavyweight Leaders: Strategic dialogues and closed-door consultations linking biotech developers with industry visionaries and global opinion leaders. Featuring keynotes and insights from renowned heavyweights across policy, academia, and top-tier venture capital, these sessions provide a premier platform to navigate international market access and global growth strategies.

Victoria Harbour Night Cruise Networking: A signature evening event bringing together industry leaders, investors, and international delegates for an exclusive night cruise along Victoria Harbour, providing an inspiring setting to deepen connections and discuss strategic partnerships against Hong Kong’s skyline.

Public Engagement Day: The convention wraps up on Saturday, September 12, with a dedicated Public Engagement Day open to the community, highlighted by two featured tracks: “Junior Scientist: Biotech STEAM Discovery Day” to inspire next-generation scientific curiosity, and “Healthy Futures—Where East Meets West” exploring integrative health, wellness innovation, and science communication.

“BIOHK2026 is engineered as Asia’s premier platform connecting source innovation to global commercialization,” stated an HKBIO spokesperson. “We invite global biotech leaders, investors, and pioneers to gather in Hong Kong this September to capitalize on new market opportunities and shape the future of global healthcare.”

Maximize Your Presence—Pre-Book Your Calendar Today!

September 9-12, 2026 | BIOHK2026—Where Leaders Unite Biotech Advances

We cordially invite global biopharma executives, researchers, investors, regulators, clinical experts, and industry leaders to gather in Hong Kong and explore the new frontiers of biotechnology.

• Registration: https://www.bio-hk.com/
• Exhibition Inquiries: kelvin.chan@hkbio.org.hk
• Media Contact: lily.wong@hkbio.org.hk

For further details, please contact us via the channels above.

About HKBIO

The Hong Kong Biotechnology Organization (HKBIO) is a leading non-profit organization dedicated to advancing the growth, internationalization, and innovation of Hong Kong’s life sciences ecosystem. Bringing together leaders from government, industry, academia, research, and capital markets, HKBIO serves as a Super-Connector, fostering cross-border collaboration, accelerating clinical translation, and supporting the commercialization of biotechnology innovation across the Asia-Pacific region. Through its initiatives, HKBIO continues to strengthen Hong Kong’s position as a leading international biotechnology and healthcare innovation hub while helping transform scientific breakthroughs into real-world healthcare solutions.

For more information, please visit https://www.bio-hk.com/.

– Two former SoftBank Vision Fund investment professionals join SBVA, expanding its global network across the U.S., Japan, and Southeast Asia
– SBVA to deepen support for portfolio companies, from identifying promising companies globally to supporting their expansion into overseas markets

SEOUL, South Korea, Aug. 27, 2026 /PRNewswire/ — SBVA (CEO: JP Lee) announced today that it has appointed two former SoftBank Vision Fund investment professionals, Kaz Yoshimaru and Chris Lee, as Venture Partners. The appointments will further strengthen SBVA’s global investment capabilities and expand its support for portfolio companies entering overseas markets and growing their businesses.

Kaz Yoshimaru holds a Bachelor of Laws and a Master of Public Administration (MPA) from the University of Tokyo, as well as an MBA from Harvard Business School. He joined SoftBank Group in 2015 and later served as an Investment Director at SoftBank Vision Fund, investing in global technology companies as part of its U.S. investment team. He invested in leading technology companies including Databricks, Wiz, Perplexity, and Sierra, while supporting their expansion into Japan and helping bridge Silicon Valley and Asia.

As a Venture Partner at SBVA, Yoshimaru will leverage his expertise and network across the U.S. technology and venture ecosystem to support a range of initiatives. He will also lead strategic advisory and structuring efforts for a new fund focused on investing in U.S. startups.

Chris Lee earned a bachelor’s degree in Economics from the University of Chicago. He later worked at CVC Capital Partners and GIC before serving as a Partner at SoftBank Vision Fund. With extensive experience in private equity and growth equity, Lee led investments in major high-growth companies across Asia, including Yanolja, Carro, Advance Intelligence Group, bKash, IYUNO, and Funding Societies, building deep investment expertise and networks across the region.

At SBVA, Chris Lee will help identify co-investment opportunities in Southeast Asia and support new fund formation, while also helping portfolio companies enter and expand in local markets.

“Kaz and Chris bring extensive investment experience and networks built through identifying and supporting innovative companies across global markets,” said JP Lee, CEO of SBVA. “We expect their addition to further strengthen SBVA’s role as a bridge between the global technology ecosystem and Asian markets.”